- Trials with a EudraCT protocol (232)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (16)
232 result(s) found for: Hemodialysis.
Displaying page 1 of 12.
EudraCT Number: 2015-002488-40 | Sponsor Protocol Number: LIPMAT | Start Date*: 2015-11-06 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: The LIPMAT study: Liposomal prednisolone to improve hemodialysis fistula maturation | |||||||||||||
Medical condition: Nonmaturation of arteriovenous vascular accesses for hemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005916-29 | Sponsor Protocol Number: IFEROS V5-1 | Start Date*: 2007-10-29 | ||||||||||||||||
Sponsor Name:Westpfalz-Klinikum GmbH | ||||||||||||||||||
Full Title: IFEROS – Influence of intravenous iron therapeutics on oxidative stress in hemodialysis patients | ||||||||||||||||||
Medical condition: stable patients on hemodialysis with renal anemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021665-68 | Sponsor Protocol Number: Citrasate01 | Start Date*: 2010-10-06 | ||||||||||||||||
Sponsor Name:University Hospital Antwerp | ||||||||||||||||||
Full Title: Comparison of Slow Efficiency dialysis (SLEDD) with Unfractionated Heparin versus Citrasate in Critically Ill Patients | ||||||||||||||||||
Medical condition: To compare the feasability, safety and efficacy of Sustained Slow Efficiency Dialys (SLEDD) using regional anticoagulation with Citrasate compared to systemic anticoagulation with Unfractionated He... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004621-26 | Sponsor Protocol Number: Devitahep | Start Date*: 2012-07-31 | |||||||||||||||||||||
Sponsor Name:Medical University Graz | |||||||||||||||||||||||
Full Title: The effect of vitamin D supplementation on immune response following hepatitis B vaccine in incident and prevalent hemodialysis patients with vitamin D deficiency | |||||||||||||||||||||||
Medical condition: The effect of vitamin D supplementation on immune response following hepatitis B vaccine in incident and prevalent hemodialysis patients with vitamin D deficiency | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019200-23 | Sponsor Protocol Number: CMEX839BDE06 | Start Date*: 2010-07-01 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A multi-center, prospective, open-label, 8-weeks study to investigate the efficacy, safety and pharmacokinetics of certoparin (3000 IU anti-Xa bolus, with the option to titrate dose) in the prophyl... | |||||||||||||
Medical condition: patients undergoing chronic dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004608-17 | Sponsor Protocol Number: SJ2021100 | Start Date*: 2021-10-18 |
Sponsor Name:AZ Sint-Jan Brugge-Oostende AV | ||
Full Title: Effectivity of a mRNA-1273 booster vaccine against Covid-19 breakthrough infections in hemodialysis patients: a multicenter interventional study | ||
Medical condition: hemodialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020492-23 | Sponsor Protocol Number: 2010-SFG-01 | Start Date*: 2010-10-21 |
Sponsor Name:Sint Franciscus Gasthuis | ||
Full Title: Pharmacokinetics of ertapenem in a three-weekly dosing regime in patients with end stage renal disease depending on hemodialysis | ||
Medical condition: Infection (bacterial) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005334-22 | Sponsor Protocol Number: 347PUNCIOHEMODIALISIS | Start Date*: 2016-05-31 |
Sponsor Name:HOSPITAL DE PALAMÓS | ||
Full Title: CLINICAL TRIAL FOR THE TREATMENT OF PAIN IN HEMODIALYSIS PUNCTURE WITH LIDOCAINE / PRILOCAINE, VERSUS CHLOROETHYL, CROSSOVER RANDOMIZED STUDY | ||
Medical condition: Hemodialysis is the most commonly used therapy for renal replacement being the arteriovenous fistula used for vascular access . Venipuncture in patients causes stress, pain and anxiety. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002195-14 | Sponsor Protocol Number: KPPM-Hx | Start Date*: 2019-11-12 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:University Hospital "Príncipe de Asturias" | ||||||||||||||||||||||||||||||||||||||
Full Title: Randomized clinical trial to assess the monocitary functionality and their relationship with the administration of intravenous iron in patient in hemodialysis according to practice guidelines or ac... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Monocyte function in patients with anemia in hemodialysis | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000930-32 | Sponsor Protocol Number: SJ2021005 | Start Date*: 2021-04-27 |
Sponsor Name:AZ Sint-Jan Brugge-Oostende AV | ||
Full Title: COVID-19: Documentation of humoral and cellular immune response of hemodialysis patients after vaccination against SARS-CoV-2 | ||
Medical condition: hemodialysis patients hemodialysis patients with comorbidities | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001573-10 | Sponsor Protocol Number: E2011HDinfection | Start Date*: 2012-01-24 | ||||||||||||||||
Sponsor Name:Hôpital Erasme | ||||||||||||||||||
Full Title: optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis. | ||||||||||||||||||
Medical condition: hemodialysis oligoanuria sepsis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-001340-22 | Sponsor Protocol Number: CathLockTrialHD | Start Date*: 2020-02-24 |
Sponsor Name:Universtitätsklinikum St.Pölten | ||
Full Title: A prospective, randomized, multicenter trial to compare a Taurolock™ based lock solution to a Citrate and Citrate/Urokinase based lock solution in tunneled hemodialysis catheters for the prevention... | ||
Medical condition: Patients requiring hemodialysis with a CVC due to renal failure of any cause. Aim of this study is to investigate different CVC lock Solutions. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004840-30 | Sponsor Protocol Number: PrepDial | Start Date*: 2020-11-04 | |||||||||||
Sponsor Name:Policlinico di Bari-UO Gastroenterologia | |||||||||||||
Full Title: Comparison of low-volume versus high-volume polyethylene glycol based bowel preparation for colonoscopy in people receiving hemodialysis: a randomized non-inferiority trial. | |||||||||||||
Medical condition: Colonoscopy in people receiving hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004794-33 | Sponsor Protocol Number: PA101B-UP-02 | Start Date*: 2016-03-25 | |||||||||||
Sponsor Name:Patara Pharma, LLC | |||||||||||||
Full Title: Treatment of Uremic Pruritus with Inhaled PA101B in Patients with End-Stage Renal Disease Requiring Hemodialysis | |||||||||||||
Medical condition: Uremic Pruritus in patients with end-stage renal disease requiring hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000043-31 | Sponsor Protocol Number: 383 | Start Date*: 2020-03-26 |
Sponsor Name:Groupe Hospitalier Paris Saint-Joseph | ||
Full Title: Efficacy and tolerance of Liraglutide for weight loss in obese type 2 diabetic hemodialysis patients | ||
Medical condition: obese type 2 diabetic hemodialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004381-25 | Sponsor Protocol Number: 1608170 | Start Date*: 2017-11-24 | |||||||||||
Sponsor Name:CHU de Saint-Etienne | |||||||||||||
Full Title: Study of the impact of a targeted decolonization of S. aureus in persistent carriers on the occurrence of S. aureus infections in hemodialysis patients | |||||||||||||
Medical condition: Hemodialysis patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018010-18 | Sponsor Protocol Number: V1.0,29.11.2009 | Start Date*: 2010-07-02 |
Sponsor Name:Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin | ||
Full Title: Multiple-dose Pharmacokinetics of Doripenem during continuous venovenous hemodiafiltration and molecular adsorbent recirculating system in ICU patients and during hemodialysis in longterm hemodialy... | ||
Medical condition: pharmacokinetics of Doripenem during CVVHDF(intensive care patients continuous venovenous haemodiafiltration), MARS(extracorporeal liver assist device, using a hollow fiber dialysis column in which... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002353-29 | Sponsor Protocol Number: HUB-NEF-HEMOCIONA.EC | Start Date*: 2019-11-12 | ||||||||||||||||
Sponsor Name:HOSPITAL UNIVERSITARI DE BELLVITGE- IDIBELL | ||||||||||||||||||
Full Title: PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY OF APIXABAN IN PATIENTS IN HEMODAFILTRATION | ||||||||||||||||||
Medical condition: Chronic kidney disease, non-valvular atrial fibrillation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004572-35 | Sponsor Protocol Number: CR845-CLIN3105 | Start Date*: 2019-06-17 |
Sponsor Name:Cara Therapeutics, Inc. | ||
Full Title: An Open-Label, Multicenter Study to Evaluate the Safety and Effectiveness of Intravenous CR845 in Hemodialysis Patients with Moderate-to-Severe Pruritus | ||
Medical condition: Moderate-to-Severe Pruritus in Hemodialysis Patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) PL (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006772-30 | Sponsor Protocol Number: 20-026 | Start Date*: 2009-03-10 | ||||||||||||||||
Sponsor Name:Medical University of Graz | ||||||||||||||||||
Full Title: Evaluation of HCV clearance by hemodialysis | ||||||||||||||||||
Medical condition: Chronic hepatitis C in patients with chronic renal failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
